Patents by Inventor Ziding Feng

Ziding Feng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240159753
    Abstract: Provided are methods and related kits for detection of early stage lung cancer, and determination of risk of harboring lung cancer.
    Type: Application
    Filed: March 31, 2023
    Publication date: May 16, 2024
    Inventors: Samir HANASH, Edwin OSTRIN, Ziding FENG
  • Publication number: 20230324394
    Abstract: Provided are methods and related kits for detection of early stage pancreatic ductal adenocarcinoma. Also provided are methods for treating a patient susceptible, or suspected of being susceptible, to pancreatic ductal adenocarcinoma.
    Type: Application
    Filed: November 10, 2022
    Publication date: October 12, 2023
    Inventors: Samir HANASH, Michela CAPELLO, Ayumu TAGUCHI, Ziding FENG
  • Publication number: 20230314436
    Abstract: Provided are methods and related kits for detection of early stage lung cancer, and determination of risk of harboring lung cancer.
    Type: Application
    Filed: March 28, 2023
    Publication date: October 5, 2023
    Inventors: Samir HANASH, Ayumu TAGUCHI, Ziding FENG
  • Publication number: 20200182876
    Abstract: Provided are methods and related kits for detection of early stage pancreatic ductal adenocarcinoma. Also provided are methods for treating a patient susceptible, or suspected of being susceptible, to pancreatic ductal adenocarcinoma.
    Type: Application
    Filed: December 15, 2017
    Publication date: June 11, 2020
    Inventors: Samir HANASH, Michela CAPELLO, Ayumu TAGUCHI, Ziding FENG
  • Publication number: 20200025766
    Abstract: Provided are methods and related kits for detection of early stage lung cancer, and determination of risk of harboring lung cancer.
    Type: Application
    Filed: February 9, 2018
    Publication date: January 23, 2020
    Inventors: Samir HANASH, Ayumu TAGUCHI, Ziding FENG
  • Publication number: 20190024184
    Abstract: Methods and kits to distinguish metastatic-lethal prostate cancer (PCa) from indolent PCa in a subject are described. The methods and kits utilize the methylation status of genetic markers. Distinguishing metastatic-lethal PCa from indolent PCa informs more directed treatments at an earlier time point than previously available.
    Type: Application
    Filed: December 22, 2016
    Publication date: January 24, 2019
    Applicant: Fred Hutchinson Cancer Research Center
    Inventors: Janet Stanford, Ziding Feng